The plant-based, cholesterol-lowering diet is associated with a reduced risk for cardiovascular disease and mortality across ...

PDS Biotechnology Corporation has announced the ... the variability in confidence intervals raises questions about the reliability of the data. The mention of the specific cohort sizes (n=53 ...

The data supports continued investigation of both agents in several ongoing and future clinical trials.” The full JAMA Oncology publication can be accessed here. About PDS BiotechnologyPDS ...

PDS Biotech is specifically addressing HNSCC ... increased from 18.4 months in 2023 to 23.9 months as the data has matured. All data are reported according to RECISTv1.1 criteria, requiring ...

Separately, PDS Biotech announced that, due to new U.S. National Institutes of Health policies regarding employee attendance at scientific conferences and meetings, the abstract “Alterations in ...

Kirk Shepard, M.D., Chief Medical Officer of PDS Biotech stated, “We continue to be excited about the strength and durability of the VERSATILE-002 data showing the longest survival reported to ...

The overall goal at A New Social is to shift the power of social networks back to the people, not the platform makers, by ...

PDS Biotechnology ( ($PDSB) ) has shared an update. On June 2, 2025, PDS Biotechnology Corporation announced the publication of three Versamune® ...